Skip to main content
TipRanks
Go Ultimate75% OFF

Compare MannKind (MNKD) vs. Competitors

2,105 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
MNKDMannKind$4.13$1.33B-17.54-18.54%Strong BuyUnlock the MNKD analyst price target with TipRanks PremiumMNKDUnlock the MNKD top-analyst price target with TipRanks Premium
LXRXLexicon Pharmaceuticals$1.79$796.97M-12.3224.31%Strong BuyUnlock the LXRX analyst price target with TipRanks PremiumMNKD vs LXRXUnlock the LXRX top-analyst price target with TipRanks Premium
INVAInnoviva$19.03$1.35B7.49-14.28%Strong BuyUnlock the INVA analyst price target with TipRanks PremiumMNKD vs INVAUnlock the INVA top-analyst price target with TipRanks Premium
SVRASavara$4.64$1.02B-7.618.92%Strong BuyUnlock the SVRA analyst price target with TipRanks PremiumMNKD vs SVRAUnlock the SVRA top-analyst price target with TipRanks Premium
XERSXeris Pharmaceuticals$16.66$3.04B-415.46129.48%Strong BuyUnlock the XERS analyst price target with TipRanks PremiumMNKD vs XERSUnlock the XERS top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
MNKDMannKind4.13-0.85-17.07%
LXRXLexicon Pharmaceuticals1.790.3322.60%
INVAInnoviva19.03-2.94-13.38%
SVRASavara4.640.4410.48%
XERSXeris Pharmaceuticals16.669.40129.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts